Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder
Clinical trial NCT00190749 · COMPLETED
Trial details
- NCT number
- NCT00190749
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2008-06-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.